Exemplos de uso de Sudden sensorineural em Inglês e suas traduções para o Português
{-}
-
Colloquial
-
Official
-
Medicine
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Of the 177 patients diagnosed with sudden sensorineural hearing loss, 95 were males and 82 females.
Sudden sensorineural hearing loss SSNHL is a loss that is greater than 30 dB in three contiguous frequencies and that occurs in less than 3 days.
Objective: to analyse the tinnitus andhearing in patients with idiopathic sudden sensorineural hearing loss treated with steroids.
A total of 277 patients with sudden sensorineural hearing loss treated at the ISSHL Outpatient Clinic were assessed between 2000 and 2010.
Given this, the FDA required manufacturers of these drugs to alert consumers about this possibility: sudden sensorineural hearing loss.
The authors considered that there was a possible association of sudden sensorineural hearing loss associated with the consumption of vardenafil.
The authors concluded that, although the data was not conclusive,there seems to be a potential link between the use of PDE5 inhibitor and sudden sensorineural hearing loss.
In a case study,observed that an young presented sudden sensorineural hearing loss, preceded by tinnitus, that was recovered after treatment.
Despite our findings, we believe that all pure-tone andspeech audiometry parameters should be an integral part of the assessment of sudden sensorineural hearing loss patients.
Based on these results,we notice that in the two cases described, the sudden sensorineural hearing loss was unilateral, accompanied by tinnitus and dizziness.
We define sudden sensorineural hearing loss as being a sensorineural hearing loss above 30dB in at least three adjacent frequencies and of sudden onset or in up to 72 hours.
Based on these reports, researchers stressed the need to investigate the potential relationship between sudden sensorineural hearing loss and use of this class of drugs.
Introduction: the association between sudden sensorineural hearing loss(sshl) and tinnitus is common but its correlation with prognosis of hearing recovery is still controversial.
Introduction: tinnitus is a hearing complex disorder and is present in up to 80% of patients with sudden sensorineural hearing loss, becoming even their main complaint.
Idiopathic sudden sensorineural hearing loss ISSHL is characterized by the occurrence of a hearing loss of at least 30 dB in three contiguous frequencies, with its onset in a period from a few hours up to three days.
Plontke et al. looked into 52 controlled trials on the treatment of idiopathic sudden sensorineural hearing loss ISSHL only to find 40 different analytical methods.
Patients were evaluated based on an observational retrospective cohort study. Individuals from the Outpatient Clinic of ISSHL, treated between 2000 and2010 who had idiopathic sudden sensorineural hearing loss were assessed.
Objective: to investigate the profile of leptin andadiponectin in onset of idiopathic sudden sensorineural hearing loss as also study their prognostic influence on hearing recovery of patients.
The vestibulo-cochlear nerve is, as the second pair of cranial nerves, the main involved one, by leading to sensorineural hearing loss,which is comprised among the neurological peripheral causes of sudden sensorineural hearing loss 2.
This study aims to establish which variables identifiable at the onset of idiopathic sudden sensorineural hearing loss have prognostic value in the final hearing recovery.
In the assessment of patients with sensorineural hearing loss, systemic disorders, especially systemic hypertension, diabetes mellitus anddyslipidemias are directly or indirectly implicated, since there is no consensus of this association regarding sudden sensorineural hearing loss.
Table 1 depicts the mean values of age,improvement rate and time of treatment onset of the sudden sensorineural hearing loss in the two groups, with their respective standard deviation and maximum and minimum values.
This is a cohort observational trial based on a prospective protocol that included patients from the sudden hearing loss ward of a university hospital affected by idiopathic sudden sensorineural hearing loss seen between 2000 and 2010.
There is a lack of consistency in the criteria used to verify hearing recovery in sudden sensorineural hearing loss patients; such inconsistencies hinder the comparison between research findings on the topic.
The effects of phosphodiesterase type 5 inhibitors in the cochlea are still uncertain due to the need for more studies with larger groups and a control group, and there is a need for otolaryngologists to add to their anamneses the possibility that patients with this type of hearing loss may be using this class of drugs,since there has been some evidence indicating that these drugs may be responsible for sudden sensorineural hearing loss.
The lack of consistency between the analytical methods used in trials on idiopathic sudden sensorineural hearing loss hinders the establishment of a proper comparison between the various treatments described in the literature.
This study aims to compare the various criteria for hearing recovery described in the literature for patients with sudden sensorineural hearing loss seen at a university hospital.
Recent concerns about thisclass of drugs and the emergence of cases of sudden sensorineural hearing loss SSNHL resulted in a requirement of the FDA Food and Drug Administration- U.S agency that regulates food and pharmaceutical products- for a more rigorous labeling.
Penido et al. observed during follow up of their patients with sudden sensorineural hearing loss that the worst results in treatment happened to older patients and those who had associated disorders: systemic arterial hypertension, diabetes mellitus and dyslipidemias.